<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <version>1.0.0</version>
    <cboCostEstimates />
    <relatedBills>
      <item>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <latestTitle>Affordable Medications Act</latestTitle>
        <type>S</type>
        <number>3411</number>
        <latestAction>
          <text>Read twice and referred to the Committee on Finance.</text>
          <actionDate>2018-09-05</actionDate>
        </latestAction>
        <congress>115</congress>
      </item>
      <item>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <latestTitle>Improving Access To Affordable Prescription Drugs Act</latestTitle>
        <type>HR</type>
        <number>1776</number>
        <latestAction>
          <text>Referred to the Subcommittee on Health.</text>
          <actionDate>2017-04-05</actionDate>
        </latestAction>
        <congress>115</congress>
      </item>
      <item>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <latestTitle>Improving Access To Affordable Prescription Drugs Act</latestTitle>
        <type>S</type>
        <number>771</number>
        <latestAction>
          <text>Read twice and referred to the Committee on Finance.</text>
          <actionDate>2017-03-29</actionDate>
        </latestAction>
        <congress>115</congress>
      </item>
    </relatedBills>
    <amendments />
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <text><![CDATA[<p><b>Expanding Access to Low Cost Generic Drugs Act</b></p> <p>This bill amends the Federal Food, Drug, and Cosmetic Act to disqualify from receiving market exclusivity a generic drug manufacturer who enters into an agreement with the patent holder for a brand name drug to delay getting the generic drug approved or to delay marketing it. </p>  <p>]]></text>
          <actionDate>2018-02-28</actionDate>
          <lastSummaryUpdateDate>2019-08-20T16:26:52Z</lastSummaryUpdateDate>
          <actionDesc>Introduced in Senate</actionDesc>
          <updateDate>2018-02-28T05:00:00Z</updateDate>
          <name>Introduced in Senate</name>
        </item>
      </billSummaries>
    </summaries>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <sponsors>
      <item>
        <firstName>Tina</firstName>
        <middleName />
        <state>MN</state>
        <bioguideId>S001203</bioguideId>
        <identifiers>
          <lisID>2365</lisID>
          <gpoId />
          <bioguideId>S001203</bioguideId>
        </identifiers>
        <fullName>Sen. Smith, Tina  [D-MN]</fullName>
        <party>D</party>
        <lastName>Smith</lastName>
        <byRequestType />
      </item>
    </sponsors>
    <notes />
    <billNumber>2476</billNumber>
    <updateDate>2019-11-15T22:00:30Z</updateDate>
    <titles>
      <item>
        <title>A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure that valid generic drugs may enter the market.</title>
        <chamberCode />
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <chamberName />
      </item>
      <item>
        <title>Expanding Access to Low Cost Generic Drugs Act</title>
        <chamberCode />
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
        <chamberName />
      </item>
      <item>
        <title>Expanding Access to Low Cost Generic Drugs Act</title>
        <chamberCode />
        <parentTitleType />
        <titleType>Display Title</titleType>
        <chamberName />
      </item>
      <item>
        <title>Expanding Access to Low Cost Generic Drugs Act</title>
        <chamberCode />
        <parentTitleType />
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <chamberName />
      </item>
    </titles>
    <createDate>2018-03-01T05:41:05Z</createDate>
    <title>Expanding Access to Low Cost Generic Drugs Act</title>
    <textVersions>
      <item>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115s2476is/xml/BILLS-115s2476is.xml</url>
          </item>
        </formats>
        <date>2018-02-28T05:00:00Z</date>
        <type>Introduced in Senate</type>
      </item>
    </textVersions>
    <recordedVotes />
    <calendarNumbers />
    <committeeReports />
    <congress>115</congress>
    <latestAction>
      <actionDate>2018-02-28</actionDate>
      <links />
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </latestAction>
    <actions>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
      <actionTypeCounts>
        <introducedInSenate>1</introducedInSenate>
        <referredToCommittee>1</referredToCommittee>
      </actionTypeCounts>
      <item>
        <actionDate>2018-02-28</actionDate>
        <committee>
          <name>Health, Education, Labor, and Pensions Committee</name>
          <systemCode>sshr00</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <type>IntroReferral</type>
        <actionDate>2018-02-28</actionDate>
        <actionCode>10000</actionCode>
        <text>Introduced in Senate</text>
        <links />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committee />
      </item>
    </actions>
    <originChamber>Senate</originChamber>
    <committees>
      <billCommittees>
        <item>
          <type>Standing</type>
          <chamber>Senate</chamber>
          <systemCode>sshr00</systemCode>
          <name>Health, Education, Labor, and Pensions Committee</name>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2018-02-28T23:36:22Z</date>
            </item>
          </activities>
          <subcommittees />
        </item>
      </billCommittees>
    </committees>
    <introducedDate>2018-02-28</introducedDate>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Government information and archives</name>
          </item>
          <item>
            <name>Intellectual property</name>
          </item>
          <item>
            <name>Marketing and advertising</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <cosponsors />
    <billType>S</billType>
    <laws />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

